166 related articles for article (PubMed ID: 35600157)
1. Pam2 lipopeptides enhance the immunosuppressive activity of monocytic myeloid-derived suppressor cells by STAT3 signal in chronic inflammation.
Zhan X; Jiang X; He Q; Zhong L; Wang Y; Huang Y; He S; Sheng J; Liao J; Zeng Z; Hu S
Cent Eur J Immunol; 2022; 47(1):30-40. PubMed ID: 35600157
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells.
Shime H; Maruyama A; Yoshida S; Takeda Y; Matsumoto M; Seya T
Oncoimmunology; 2017; 7(1):e1373231. PubMed ID: 29296526
[TBL] [Abstract][Full Text] [Related]
3. Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling.
Maruyama A; Shime H; Takeda Y; Azuma M; Matsumoto M; Seya T
Biochem Biophys Res Commun; 2015 Feb; 457(3):445-50. PubMed ID: 25596131
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells.
John V; Kotze LA; Ribechini E; Walzl G; Du Plessis N; Lutz MB
Front Immunol; 2019; 10():2826. PubMed ID: 31849990
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation.
Lee JM; Kim EK; Seo H; Jeon I; Chae MJ; Park YJ; Song B; Kim YS; Kim YJ; Ko HJ; Kang CY
Eur J Immunol; 2014 Jun; 44(6):1672-84. PubMed ID: 24659444
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells in
Fresno M; Gironès N
Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
[TBL] [Abstract][Full Text] [Related]
7. Persistent accumulation of circulating monocytic myeloid-derived suppressor cells contributes to post-infectious immunosuppression in renal transplant recipients with bacterial infection: A pilot study.
Jiang Y; Feng S; Ji J; Lin Z; Zhang X
Transpl Immunol; 2018 Jun; 48():10-17. PubMed ID: 29477752
[TBL] [Abstract][Full Text] [Related]
8. TLR1/TLR2 signaling blocks the suppression of monocytic myeloid-derived suppressor cell by promoting its differentiation into M1-type macrophage.
Deng Y; Yang J; Qian J; Liu R; Huang E; Wang Y; Luo F; Chu Y
Mol Immunol; 2019 Aug; 112():266-273. PubMed ID: 31212097
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling.
Zhai N; Li H; Song H; Yang Y; Cui A; Li T; Niu J; Crispe IN; Su L; Tu Z
PLoS One; 2017; 12(1):e0170516. PubMed ID: 28114346
[TBL] [Abstract][Full Text] [Related]
10. HCV-Associated Exosomes Upregulate RUNXOR and RUNX1 Expressions to Promote MDSC Expansion and Suppressive Functions through STAT3-miR124 Axis.
Thakuri BKC; Zhang J; Zhao J; Nguyen LN; Nguyen LNT; Schank M; Khanal S; Dang X; Cao D; Lu Z; Wu XY; Jiang Y; El Gazzar M; Ning S; Wang L; Moorman JP; Yao ZQ
Cells; 2020 Dec; 9(12):. PubMed ID: 33353065
[TBL] [Abstract][Full Text] [Related]
11. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
[TBL] [Abstract][Full Text] [Related]
12. Modified method for differentiation of myeloid-derived suppressor cells
Zhou H; Xie Z; Morikawa N; Sakurai F; Mizuguchi H; Okuzaki D; Okada N; Tachibana M
Biochem Biophys Rep; 2023 Mar; 33():101416. PubMed ID: 36605123
[TBL] [Abstract][Full Text] [Related]
13. Functional Assays Evaluating Immunosuppression Mediated by Myeloid-Derived Suppressor Cells.
Reuven O; Mikula I; Ashkenazi-Preiser H; Twaik N; Ben-Meir K; Meirow Y; Daniel L; Kariv G; Kurd M; Baniyash M
Curr Protoc; 2022 Oct; 2(10):e557. PubMed ID: 36282094
[TBL] [Abstract][Full Text] [Related]
14. An In Vivo Mouse Model for Chronic Inflammation-Induced Immune Suppression: A "Factory" for Myeloid-Derived Suppressor Cells (MDSCs).
Ben-Meir K; Twaik N; Meirow Y; Baniyash M
Curr Protoc; 2022 Sep; 2(10):e558. PubMed ID: 36239438
[TBL] [Abstract][Full Text] [Related]
15. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
[TBL] [Abstract][Full Text] [Related]
17. TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide.
Yang F; Li Y; Wu T; Na N; Zhao Y; Li W; Han C; Zhang L; Lu J; Zhao Y
J Mol Med (Berl); 2016 Aug; 94(8):911-20. PubMed ID: 26936474
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
[TBL] [Abstract][Full Text] [Related]
19. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
Front Immunol; 2020; 11():613215. PubMed ID: 33679700
[TBL] [Abstract][Full Text] [Related]
20. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability.
Ribechini E; Eckert I; Beilhack A; Du Plessis N; Walzl G; Schleicher U; Ritter U; Lutz MB
JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
